Rilonacept (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Rilonacept" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
9,274th place
5,856th place
doi.org
- Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, et al. (October 2009). "The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study". Annals of the Rheumatic Diseases. 68 (10): 1613–7. doi:10.1136/ard.2009.108936. PMC 2732898. PMID 19635719.
drugs.com
- "Arcalyst FDA Approval History - Drugs.com". Archived from the original on 2012-05-16. Retrieved 2012-05-08.
europa.eu
ema.europa.eu
- "Rilonacept Regeneron (previously Arcalyst) EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 18 March 2021.
fda.gov
fda.gov
- "FDA Approves First Treatment for Disease That Causes Recurrent Inflammation in Sac Surrounding Heart". U.S. Food and Drug Administration (FDA). 18 March 2021. Retrieved 18 March 2021.
This article incorporates text from this source, which is in the public domain.
accessdata.fda.gov
- "Drug Approval Package: Arcalyst (Rilonacept) NDA #125249". U.S. Food and Drug Administration (FDA). 2 May 2008. Retrieved 20 March 2021.
medpagetoday.com
- "Medical News: FDA Panel Nixes Gout Drug - in Rheumatology, General Rheumatology from MedPage Today". 8 May 2012. Archived from the original on 2012-05-21. Retrieved 2012-05-08.
nih.gov
pubmed.ncbi.nlm.nih.gov
- Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, et al. (October 2009). "The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study". Annals of the Rheumatic Diseases. 68 (10): 1613–7. doi:10.1136/ard.2009.108936. PMC 2732898. PMID 19635719.
- "Molecule of the month. Rilonacept". Drug News & Perspectives. 21 (4): 232. May 2008. PMID 18560622.
dailymed.nlm.nih.gov
- "Arcalyst- rilonacept injection, powder, lyophilized, for solution". DailyMed. Retrieved 18 March 2021.
ncbi.nlm.nih.gov
- Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, et al. (October 2009). "The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study". Annals of the Rheumatic Diseases. 68 (10): 1613–7. doi:10.1136/ard.2009.108936. PMC 2732898. PMID 19635719.
web.archive.org
- "Arcalyst FDA Approval History - Drugs.com". Archived from the original on 2012-05-16. Retrieved 2012-05-08.
- "Medical News: FDA Panel Nixes Gout Drug - in Rheumatology, General Rheumatology from MedPage Today". 8 May 2012. Archived from the original on 2012-05-21. Retrieved 2012-05-08.